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Abstract: Background: The wild population of spotted golden thistle, Scolymus maculatus, which
belongs to the Compositae family, is believed to be one of the multi-curative wild plants mentioned in
Flora Palaestina. This study aims to disclose the phytochemical composition, antioxidant potential,
and antimicrobial activity of wild S. maculatus collected from the farms of Kabul, a village in
northwest Galilee, for the first time. Methods: The phytochemical components of crude S. maculatus
extracts from methanol, ethyl acetate, and n-hexane solvents were separated and identified using
gas chromatography-mass spectrometry (GC-MS) in the electron impact (EI) mode. The free radical
scavenging of the plant extracts was measured by DPPH assay. The microdilution test was used to
determine the minimum inhibitory concentrations (MICs) of different S. maculatus extracts and to
evaluate their antimicrobial activities. Results: Thirty-two phytochemicals were found in S. maculatus
extracts including stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and β-amyrin. Phytochemicals,
such as 2-linoleoylglycerol, γ-sitosterol, β-amyrin, lupeol, (3α)-12-oleanen-3-yl acetate, and lupenyl
acetate, were found to dominate the methanol extract. Most of these compounds were also observed in
ethyl acetate and n-hexane extracts, but at different levels, in addition to some other minor compounds.
The various extracts were investigated for their antioxidant and antimicrobial activity. The ethanolic
and the methanolic extracts were shown to exhibit the highest free radical scavenging by DPPH assay
with a half-maximally effective concentration (EC50) of 0.37 and 0.65 mg/mL respectively, while the
other three extracts (aqueous, ethyl acetate and n-hexane) were less active and their EC50 (effective
concentration at which DPPH radical was scavenged by 50%) were above 1.0 mg/mL. Moreover,
MICs were determined to be effective against Staphylococcus aureus, Salmonella typhimurium, and
Candida albicans microorganisms. Ethyl acetate and the ethanolic extracts are active against the three
types of microorganisms at a minimum inhibitory concentration (MIC) of 0.5 mg/mL, while aqueous
and the n-hexane extracts are inactive against Salmonella typhimurium. Conclusions: The results
show that S. maculatus extracts are a rich source of compounds that can play an important role in
human health, and in a broader context, in the treatment of various diseases, such antimicrobial and
antioxidant-related ailments.
Keywords: Scolymus maculatus; phytochemicals; GC-MS analysis; herbal medicine; free radical
scavenging; antioxidant; antimicrobial; DPPH assay
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1. Introduction
Plant-based nutrients and natural products have long been considered to be linked with human
health and even evidenced to reduce risks of chronic human illnesses, such as inflammation [1–3],
diabetes [4], cancer [5,6], and microbial-related diseases [7–11]. To date, herbal medicine is widely
practiced in Palestine [12]. Well-reputed, it plays an integral part in the cultural heritage and public
healthcare practices of the region. A paucity of herbal products used in folk medicine has been
scientifically investigated and recorded [13,14]. The efficacy, safety, toxicity, dosage, and the usage
instructions for medicinal plants are generally transmitted verbally from one generation to another [14].
One of the putative multi-curative wild herbal plants of Flora Palaestina is the spotted golden thistle,
S. maculatus (Compositae family). This wild plant is very common in the Mediterranean region [15].
Its shape is very similar to the famous milk thistle plant, Silybum marianum (L.), which is used to
protect the liver. S. marianum’s main active ingredients are silybin, silydianin, and silychristine,
collectively known as silymarin [15]. S. maculatus, however, is also believed to contain other useful
phytochemicals that may prevent and treat diseases, such as liver disease, cancer, and diabetes.
Moreover, a stem decoction is traditionally prepared to treat intestinal and kidney inflammation [15].
In light of this, wild S. maculatus phytochemicals from methanol, ethyl acetate, and n-hexane solvents
were investigated using gas chromatography-mass spectrometry (GC-MS) in the electron impact (EI)
mode to identify authentic principal compounds. Thirty-two phytochemicals were detected for the
first time in S. maculatus. Moreover, in vitro antioxidant activities were tested using DPPH assay. MICs
were determined for effectiveness against Staphylococcus aureus (S. aureus), Salmonella typhimurium, and
Candida albicans microorganisms.
2. Materials and Methods
2.1. Plant Collection and Extract Preparation
Whole S. maculatus plants, comprising stems and flowers, were collected from the farms of
the village of Kabul in the northwest of Galilee during October 2014. The plant was identified and
authenticated by Dr. Khaled Sawalha, a botanist from the Biology Department of Al-Quds University.
The specimens were washed with distilled water and dried in the shade for three weeks. Two hundred
milliliters each of water, methanol, ethanol, ethyl acetate, and n-hexane were added separately to
the dried ground plant material (20 g) in a beaker, and all the samples were sonicated for 60 min at
45 ◦C, then left in a dark glass bottle for 24 h for complete extraction. The extracts were filtered by
passing the solvents through a 0.2 µm filter. Ten milliliters were taken from the extracts for GC-MS
tests. The solvent remaining from each extract was evaporated with a rotary vacuum evaporator under
reduced pressure. The yields of the extracts (w/w%) were 3.3%, 3.7%, 2.4%, 7.9%, and 2.3% for aqueous,
methanolic, ethanolic, ethyl acetate, and n-hexane, respectively. The crude extracts were dissolved
in DMSO to prepare stock solutions with a 16.0 mg/mL concentration, then subjected to free radical
scavenging tests using DPPH assay. Microdilution tests were conducted to determine MICs of the
extracts against Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms.
The chemical compositions of the three extracts were verified by GC-MS.
2.2. Instrumentation
The extracts were analyzed using a Perkin Elmer, Clarus gas chromatograph connected to a Clarus
600 C mass spectrometer (GC-MSPerkinElmer, Inc, Shelton, CT, USA). The GC-MS was operated in
the electron impact ionization mode (EI) at 70 eV. A Perkin Elmer autosampler was used with 2 mL
vials. The capillary GC column (DB-5 MS, Agilent Technologies, Inc, Santa Clara, CA, USA) was
equipped with fused silica that consisted of 5% diphenyl polysiloxane and 95% dimethyl polysiloxane,
28 m × 0.25 mm, with a coating film thickness of 0.25 µm (Restek Corporation, Bellefonte, PA, USA).
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2.3. GC-MS Chromatographic Condition
The flow rate of the carrier gas was 1 mL He/min. The injector temperature was set at 235 ◦C,
the source temperature at 250 ◦C, and the interface temperature at 260 ◦C. A split ratio of 1:20 was
adopted during the entire analysis. The column gradient temperature was held at 50 ◦C for two
minutes, then raised from 50 ◦C to 180 ◦C at a ramp rate of 5 ◦C/min and from 180 ◦C to 280 ◦C at a
ramp rate of 15 ◦C/min and held there for an extra five minutes. A solvent cut time of 4.5 min was used
to eliminate the solvent’s gigantic peak. The mass range was from 50 up to 480 Da, with a scan interval
of 0.2 seconds. The identification of compounds was mainly based on matching their MS spectra with
those of NIST mass spectral library.
2.4. Free Radical Scavenging Capabilities of Extracts
The free radical scavenging of different concentrations of the S. maculatus plant extracts was
measured by DPPH assay [16]. One-milliliter portions of the plant extract were added to one-milliliter
ethanolic DPPH solution (with a concentration of 100 ppm). The assay was performed using two-fold
serial dilution by DMSO, starting from the stock solution of the plant extract. The mixture was shaken
strongly and allowed to stand for 30 min at room temperature in a dark place. The absorbance of the
solution was measured at 517 nm and converted into a percentage of free radical scavenging (FRS%)
using the following equation:
FRS% = 100 × {1 − [(Asample − Ablank))/(Acontrol − Ablank)]}
where, Asample is the absorbance of the mixture (plant extract and DPPH), Ablank is the absorbance of
the plant extract solution, and Acontrol is the absorbance of the ethanolic solution of DPPH.
Free radical scavenging at each concentration was repeated four times, and the data were expressed
as the average ± the standard error of the means of the four experiments. Gallic acid was used as a
positive control. The scavenging potential of the gallic acid and the various extracts was evaluated
by the DPPH assay test and was expressed in terms of half-maximal effective concentration (EC50),
where EC50 is defined as the concentration that causes a decrease in the initial DPPH concentration by
50%. The EC50 value was determined by extracting the equation for the linear part of the graph and
substituting 50% for the y value, while calculating the concentration value of the x-axis.
2.5. Antibacterial and Antifungal Activity
Microdilution tests were used to determine the MICs of the different samples. The broth
microdilution assay was performed using twofold serial dilution in brain heart infusion (BHI) broth.
The test was carried out in 96-well flat-bottomed microtitration plates. The cell suspension was
prepared in BHI broth with an optical density equivalent to 0.5 of the McFarland standards, and diluted
1:100 in BHI broth to obtain a final concentration of 5× 105 colony-forming units per milliliter (CFU/mL).
Controls with broth only and broth with bacteria without any of the antibacterial agents were also
included in each plat. One hundred µl of the antibacterial agent were put in the first microplate well
and serially diluted in BHI broth. One hundred µl, corresponding to 5 × 105 CFU/mL, were added to all
the wells. The plates were incubated at 37 ◦C for 18 h overnight. Erythromycin was used as a positive
control for S. aureus, while nystatin was used as a positive control for Candida albicans and Tetracycline
for Salmonella typhimurium strain LT2. The minimum inhibitory concentration (MIC) was defined as
the lowest concentration able to inhibit the visible growth of bacteria in triplicate wells. After the MIC
was visually determined, twenty microliters of p-iodonitrotetrazolium violet (8 mg/mL EtOH) were
added to each well. The plate was incubated for another 30 min and assessed visually for any change
in color from yellow to pink, which would indicate the reduction of dye due to bacterial growth.
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2.6. Statistical Analysis
Statistical analyses were performed using Excel spreadsheet software (v16.0, Microsoft, Redmond,
WA, USA). All experiments were conducted in quadruplicate, and the data were expressed as an
average ± standard deviation. A p-value (calculated by t-test) of less than 0.05 was considered
statistically significant.
3. Results and Discussion
In this study, the phytochemical composition of wild S. maculatus methanol, ethyl acetate and
n-hexane crude extracts was revealed. GC-MS screening in the electron impact mode (EI) revealed
about 32 compounds for the first time. A satisfactory resolution and elution time were obtained on
the capillary GC DB-5 column used (Figure 1). Of the 32 compounds seen in Table 1 and Figure 2,
stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and α-amyrin are known to exhibit important
pharmacological activity, in particular anticancer, anti-inflammatory, and antibacterial activity [17–19].
Phytochemicals, such as 2-linoleoylglycerol (5.87%), γ-sitosterol (5.73%), β-amyrin (15.98%), lupeol
(22.25%), (3α)-12-oleanen-3-yl acetate (9.14%), and lupenyl acetate (18.11%,) dominated the methanol
extract (see Table 1 and Figures 1 and 2). Almost all of these compounds were observed in ethyl acetate
and n-hexane extracts, but in different proportions.
Table 1. Phytochemical percentages and retention times for wild S. maculatus extracts of methanol,
ethyl acetate, and n-hexane, identified by gas chromatography-mass spectrometry (GC-MS).
Phytochemical Names and Retention Times Area %
No. Compound Name RT (min) Methanol Ethyl Acetate n-Hexane
1 1-Ethylbutyl hydroperoxide 9.054 6.42
2 1-Ethyl-2-heptylcyclopropane 16.29 0.32
3 Acetoglyceride 18.09 1.19
4 2,4-Decadienal 20.303 1.78
5 Nonylcyclopropane 21.89 0.63
6 (E)-3-Octadecene 26.88 0.59
7 Coniferyl alcohol 30.64 0.37
8 6,10,14-Trimethyl-2-pentadecanone 32.36 0.24 0.40
9 Ethyl palmitate 35.36 0.99
10 Methyl linoleate 37.27 0.97
11 14-Octadecenoic acid, methyl ester 37.38 0.30 0.24
12 Ethyl linolelaidate 38.455 12.48
13 Ethyl (9E)-9-octadecenoate 38.554 2.35
14 Palmitamide 39.00 42.67 11.97
15 Doconexent 40.08 0.69 2.61
16 Oleamide 42.04 5.08 2.90
17 Octyl cyclohexanecarboxylate 42.44 1.27 0.74
18 Tetracosane 44.4 2.15 0.28
19 Diploptene 45.16 15.68
20 2-Linoleoylglycerol 47.08 5.87 1.46 0.39
21 Spinacene 48.49 0.47 0.32
22 Tetratriacontane 49.68 2.34 1.01
23 Unknown 54.23 2.04
24 Stigmasterol 57.64 2.55 0.27
25 γ-Sitosterol 59.58 5.73 0.22 1.59
26 β-Amyrin 61.19 15.98 0.61 5.44
27 Stigmasterol acetate 61.33 1.27
28 Lupeol 63.04 22.25 10.05
29 Stigmastan-3,5-diene 63.76 4.21
30 (3α)-12-Oleanen-3-yl acetate 64.23 9.14 12.11 4.22
31 Lupenyl acetate 66.47 18.11 26.82 11.03
32 Unknown 67.33 11.26 0.16 7.78
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Figure 2. Phytochemicals stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and beta-amyrin present in
wild Scolymus maculatus extracts of methanol, ethyl acetate, and n-hexane, identified by GC-MS.
It is worth noting that sitosterol has been reported to possess antibacterial potential [20].
Stigmasterol exhibits antibacterial activity against methicillin-resistant Staphylococcus aureus [16]
and has be n reported as well t significantly inhibit tumor pr mo ion in two-stage carcinogenesis
in mice [21]. A mixture of sitosterol and stigmasterol has been shown to possess anti-inflammatory
activity after topical application [22]. Therefore, it is expected that the presence of such sterols in
S. maculatus would be of paramount importance for combating and curing diseases.
Lupeol (Figure 2), another significant phytochemical in S. maculatus, is about 22% in the identified
peaks in the methanol extract. Numerous preclinical animal studies suggest that lupeol has potential as
anti-inflammatory, anti-microbial, anti-protozoal, anti-proliferative, anti-invasive, anti-angiogenic and
cholesterol-lowering agent [23]. β-amyrin (Table 1 and Figure 2), which was found in the methanol
and n-hexane extract in about 16% and 5.44%, respectively, were reported recently to have significant
anticancer activity [24], and a recent study highlights the potential of both lupeol and stigmasterol as
new, promising anti-MRSA (methicillin-resistant Staphylococcus aureus) agents [16]. β-amyrin from
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L. microcladia natural product has shown potential antibacterial activity [25]. The authors suggest
intensifying the study on L. microcladia as a source of β-amyrin. Moreover, among the three molecules
that were isolated from S. globulifera, lupeol and β-amyrin exhibit potential as new anti-Enterococcus
compounds [26]. Growth inhibition of Streptococcus from the oral cavity by α-and β-amyrin terpenoids
and α-amyrin esters have also been reported [27]. Table 1 shows the presence of α,β-unsaturated
aliphatic aldehydes, such as 2,4-decadienal. Recent studies also demonstrate the capability of such a
compound to combat bacterial growth [28,29].
The antioxidant reacts with the stable free radical DPPH and converts it to 1, 1-diphenyl-2-picryl
hydrazine. The ability to scavenge the free radical DPPH was measured at an absorbing wavelength of
517 nm. All the extracts of S. maculatus were tested for their free radical scavenging activity. The EC50
values of the five extracts are shown in Table 2 and Figure 3. The ethanolic extract is the most active
(probably containing a higher concentration of antioxidants) while the n-hexane extract is the least
active one.
Table 2. The half-maximal effective concentration (EC50) values of the radical scavenging activity of
five S. maculatus extracts: aqueous, methanolic, ethanolic, ethyl acetate, and n-hexane (n = 4).
S. maculatus Extract Type EC50 (mg/mL)
Aqueous extract 1.27
Methanolic extract 0.65
Ethanolic extract 0.37
Ethyl acetate extract 1.08
n-hexane extract >2.0
Antibacterial activity was anticipated because of the presence of compounds, such as lupeol,
amyrin, sitosterol, and stigmasterol, which have shown potential antibacterial potential [20,25,30].
Therefore, the aqueous, methanol, ethanol, ethyl acetate, and n-hexane extracts of wild S. maculatus were
evaluated in comparison to tetracycline, erythromycin and nystatin positive controls. The aqueous
extract was deliberately used to imitate the usual method of plant decoction. The MICs against
Staphylococcus aureus, Salmonella typhimurium, and Candida albicans microorganisms were determined.
The ethyl acetate and the ethanolic extracts were active against the three types of microorganisms,
with a MIC of 0.5 mg/mL, while the aqueous and the n-hexane extracts were inactive against
Salmonella typhimurium (Table 3). The methanolic extract was active against Staphylococcus aureus and
Candida albicans but not against Salmonella typhimurium.
Table 3. The minimum inhibitory concentrations (MICs) of five S. maculatus extracts (aqueous, methanolic,
ethanolic, ethyl acetate, and n-hexane) against Staphylococcus aureus, Salmonella typhimurium, and Candida
albicans microorganisms.
Type of
Extract/Microbial Strain
Staphylococcus
aureus
Salmonella
typhimurium
Candida
albicans
Aqueous extract 0.5 mg/mL >4.0 mg/mL 1.0 mg/mL
Methanolic extract 0.5 mg/mL >4.0 mg/mL 0.5 mg/mL
Ethanolic extract 0.5 mg/mL 0.5 mg/mL 0.5 mg/mL
Ethyl acetate extract 0.5 mg/mL 0.5 mg/mL 0.5 mg/mL
n-hexane extract 1.0 mg/mL >4.0 mg/mL 0.5 mg/mL
Tetracycline - 0.01 mg/mL -
Erythromycin 0.0078 mg/mL - -
Nystatin - - 0.00312 mg/mL
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4. Conclusions
Thirty-two volatile components were detected in wild S. maculatus for the first time. Lupeol was
the predominant co ponent, with a percentage exceeding 22% in methanol. Lupeol acetate was the
principle phytochemical in the ethyl acetate extract (26%) and to a lesser extent (11%) in n-hexane.
Stigmasterol, γ-sitosterol, lupeol, lupeol acetate, and β-a yrin, which are reported here for the first
time as phytochemical components in S. aculatus, are biologically active compounds according to
scientific literature and most likely responsible for some of the activities of wild S. maculatus. Isolation of
all antioxidant and antimicrobial chemicals from the most active extracts and testing their contribution
to the biological activities of wild S. maculatus and potential synergism is recommended. The findings
disclosed herein are important and may suggest the i portance of consuming S. maculatus as food.
Enriched extracts could be prepared that possess certain activity beneficial to human health, and in a
broader context, that could be useful for the treatment of various diseases. As well, S. maculatus could
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be a source of promising lead compounds for the development of new treatments for microbial-related
diseases and some other diseases.
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